chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient experienced low grade fever of 101 F, nausea and diarrhea x 3 episodes, general feeling of moderate body aches, lightheadedness. Patient reported to local hospital ER (non-descript from patient) for care 03AUG2023 @ 05:00PM. Patient reports Treatment with moltrin and tylenol then, discharged at 02:00 AM 04AUG2023. He was given instructions to follow up with health provider. He followed up with Medical Clinic, vitals wnl and had 3  episodes of diarrhea since awaking at 07:00 AM 04AUG2023 and reports a 5/10 generalized pain throughout body. Patient discharged with no restricitions and counseled to return as needed if symptoms start to worsen again.
Severe epigastric pain for one  hour with nausea, then nausea/queasy/sore abdomen for 24 hours.; Severe epigastric pain for one  hour with nausea, then nausea/queasy/sore abdomen for 24 hours.; Severe epigastric pain for one hour with nausea, then nausea/queasy/sore abdomen for 24 hours.; This is a spontaneous report from a  non-contactable consumer.  A female patient of an unspecified age started received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number EK9231);  via an unspecified route of administration in the Left arm, on 06Jan2021 at 12:45 as  SINGLE DOSE for covid-19 vaccination. Medical history included hypothyroidism. Concomitant medication in two weeks of received vaccine was received (details were not provided).  The patient previously took lisinopril and experienced drug hypersensitivity.  The facility in which the vaccine was given was a hospital. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 06Jan2021 at 14:00 The patient experienced Severe epigastric pain for one hour with nausea, then nausea, queasy and sore abdomen for 24 hours. Treatment included Zofran sublingual as a result of severe epigastric pain, nausea/queasy and sore abdomen. The clinical outcome of the events Severe epigastric pain was recovered on 06Jan2021 at 15:00 which nausea, queasy and sore abdomen was recovered on 07Jan2021.    No follow up attempts are possible. No further information is expected.
Information has been received from a female consumer who on 25-NOV-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck). On 28-NOV-2008 the patient developed giant urticaria. On 5-DEC-2008 the patient developed low grade fever, 100.4 degrees. Additional information has been requested.
4 inch diameter erythema/induration at site of VARIVAX - Treated with KEFLEX, ibuprofen
Headache, Loss of appetite, incontinence, stuffy nose (blood in mucus), weak (unstable walking), lackadaisical, chills, soreness at injection site        After 24 hours of unsent of symptoms began feeling better.
general fatigue, headache, axillary soreness, redness/soreness at injection site, warmth, nausea, headache
Weakness was observed the next day after vaccination.   Sharp, acute joint pain in knee area that went away right after.  The pain feels more of a nerve pain, inside the bone type of pain.  It still exists three weeks after the vaccine.
Patient mother deliberately wrote wrong DOB for patient so her 11 year-old child could get vaccinated. Patient will receive 2nd dose after he turns 12.
About two hours after my 2nd Covid shot, I felt like I had been in a terrible accident and had terrible muscle soreness in my neck and shoulders. Over one month later and my shoulder still ache and hurt?. My range of turning My neck to either side is getting better but it still HURTS.
Patient has reported persistent pain in the lateral right arm region since the time of the vaccine administration to the present.  She was evaluated by her personal MD.
having a sore arm; headaches; This is a spontaneous report from a contactable Consumer (patient). This 89-year-old male patient received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiration date: 30Apr2021) via an unspecified route of administration on 12Jan2021 12:15 at single dose for covid-19 immunisation. Medical history included ongoing hearing issue from 10 years ago and wearing hearing aids, surgery for dislocated vertebrae in neck two years ago, currently having 6 screws in his neck, ongoing Spinal stenosis, ongoing allergic to penicillin and sulfa. Concomitant medications included paracetamol (TYLENOL) from an unspecified date and ongoing for pain from spinal stenosis. The patient went on a 0.5 mile walk everyday in his neighborhood. He got his pain in his back and shoulders after he finished the walk so he took Tylenol. He didn't take it on a regular basis though. He just took a couple of tablets. The patient got his first injection of the COVID 19 vaccine at 12:15 on 12Jan2021. After he got home , he went online to find out more information on the vaccine. He was originally concerned about having a sore arm, headaches, and all this on Jan2021. He asked about the medication online. It said you can take Tylenol after the vaccine, but do not take it before the vaccine, and that was exactly what he did. He took 2 Tylenol an hour before the vaccine. The doctor was concerned about his age because of his immune system being borderline. That was why he got the vaccine. Outcome of the events was unknown.
Shoulder and arm were extremely painful, and full use of arm was limited for several days.  The is still shoulder pain with certain movements and has not fully subsided
20/168 devel erythematous edematous deltoid regions the size of a baseball; 60 /168 devel extremely sensitive to touch reaction x 48 hrs p/inject in the deltoid region;
This spontaneous report was received from a nurse refers to an unknown number of patients of unknown age and gender. No concurrent condition or medical history was reported. On an unknown date the patients were vaccinated with improperly stored (temp 12 degree Celsius, time 6 hours) RECOMBIVAX HB (lot # L025738, exp. 14-AUG-2017, dose and route of administration not provided). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issued was involved. This is one of the several reports from th same reporter link. Additional information is not expected since the reporter did not wish further contact.
This spontaneous reprot as received from a licensed practical nurse refers to multiple patients of unknown age and gender. There were no concomiatnt medications, concurrent condditions and medical history reported. On 26-OCT-2015, the multiple, unspecified patients received improperly stored doses of VAQTA lot # L028666 exp. 04-NOV-2016 (route of administration, dose were not reported). There were no adverse effects reproted. This is one of several reports received from the same reporter. Additional informaiton has been requested.
Fever of 102 for 2 days, Severe rash covering entire body for 7 days, was put on Prednisone then rash resolved after 12 days
alopecia areata; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 7-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 08Nov2021 13:30 (Batch/Lot number: unknown) at the age of 7 years as dose 1, single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: INFLUENZA VACCINE taken for immunisation, administration date 23Oct2021. The following information was reported: ALOPECIA AREATA (non-serious) with onset 19Nov2021, outcome "unknown", described as "alopecia areata". The event "alopecia areata" was evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of alopecia areata.    The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient felt like her throat was tight, no hives or difficulty breathing. Pt received Benadryl 50mg po. Within 30 minutes, patient's symptoms had resolved.
ras the second dose / she was able to receive her second scheduled dose of Astra Zeneca.; This spontaneous case was reported by a health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS  as the second dose / she was able to receive her second scheduled dose of Astra Zeneca.) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ASTRA ZENECA COMPOUND 677 for an unknown indication.    No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient received second dose of ASTRA ZENECA COMPOUND 677 (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS / she was able to receive her second scheduled dose of Astra Zeneca.). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS she was able to receive her second scheduled dose of Astra Zeneca.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment or adverse event information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Significant follow up appended to AER
tingling/numbness of lips and tip of tongue; tingling/numbness of lips and tip of tongue; tingling/numbness of lips and tip of tongue; tingling/numbness of lips and tip of tongue; flushed face; slight constricting of throat; This is a spontaneous report from a contactable consumer. This 42-year-old female consumer reported.   A 42-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 12:15 (age at the time of vaccination was 42-year-old) as dose 1, single for COVID-19 immunization. Medical history included urticaria and dermatitis contact from an unknown date and unknown if ongoing, I get hives from dermal contact with certain plants/animals/chemicals from an unknown date and unknown if ongoing, allergy to chemicals and allergy to animals from an unknown date and unknown if ongoing. The patient's concomitant medications was not reported. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient did not receive any other medication prior to COVID-19 Vaccine. The patient reported that after 15 minutes of injection, the patient experienced tingling/numbness of lips and tip of tongue, flushed face and slight constricting of throat on 30Mar2021 12:45. Drove to emergency but did not go in, effects began to subside 30 minutes later. No treatment was received for all the events. Outcome of all the events was reported as recovered on 30Mar2021.   No follow-up attempts are possible. No further information is expected.
There were no side effects, per CDC we do have to repeat dose when he reaches appropriate age, right now he needs (DTa-IPV-hep B).
Persistent headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Persistent headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Dec-2021, the patient experienced HEADACHE (Persistent headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Persistent headache, at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) for Persistent headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Persistent headache) had not resolved.            No concomitant medications were reported.
itching all over; series of rashes on my torso; blister type itchy bumps; my skin is crawling; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE ;Lot Number: EW0178) via an unspecified route of administration in the left arm on 05May2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included severe reaction to H1N1 vaccination (allergy to vaccine) in 2010. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19.  The patient did not receive any concomitant medications within two weeks of the COVID vaccine. The patient was allergic to fluoroquinolones and clobetasol (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on an unknown date at 08:30 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Jun2021 at 08:00 the patient experienced itching all over, series of rashes on torso, blister type itchy bumps, skin crawling . The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the reported events. The clinical outcome of the event itching all over, series of rashes on torso, blister type itchy bumps, skin crawling were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Rt upper arm somewhat swollen, red, warm , itchy and a "little painful." Swelling was going down when benadryl given.
- 1st week of Aug - sick for a week. 04 tested negative/6 Aug 2021 - positive; Sneezing, congestion, running nose, cough. fever, chills and aches - lasted about week at 102.7 temperature for 2 days. Sore throat and congestion went off 10 days. I still have loss of taste and smell.
Flu symptoms began the night of the vaccination.  Symptoms were severe throughout the following 36 hours.  Symptoms seem to be subsiding after 48 hours.
Diagnosed with Covid-19; Sinus discomfort; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with Covid-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced COVID-19 (Diagnosed with Covid-19) (seriousness criterion medically significant), SINUS DISORDER (Sinus discomfort) and PYREXIA (fever). On 26-Apr-2021, SINUS DISORDER (Sinus discomfort) and PYREXIA (fever) had resolved. At the time of the report, COVID-19 (Diagnosed with Covid-19) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, SARS-CoV-2 test positive: (abnormal) HCP diagnosed patient with Covid-19, as test results were positive..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported.  Description: The patient was currently in quarantine status and would be until 03 May 2021. SARS-COV-2 TEST POSITIVE (diagnosed with Covid-19).  No treatment information provided.  Company comment: Based on biological implausibility the event of COVID-19 infection is assessed as unlikely related to mRNA-1273. Additionally reported sinus discomfort and fever were assessed as symptoms of COVID-19 infection thus also unlikely related.; Sender's Comments: Based on biological implausibility the event of COVID-19 infection is assessed as unlikely related to mRNA-1273. Additionally reported sinus discomfort and fever were assessed as symptoms of COVID-19 infection thus also unlikely related.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No Concomitant medications were provided.  It was reported that 196 patients had received 0.25 ml of Bivalent Moderna vaccine.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine  No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live significant follow up: Added age group and updated narrative.
My heart rate went up to 150 that Friday night and didn't get to a normal heart rate till about 6 hours later. Then it happened again on Sunday night it went up to 120 and then went back down in about 30 minutes. And then 9 days later my heart rate in the Tuesday evening went up to about 165 and then it took about 6-7 hours for it to go back down, it was in the middle of the night. Nov 10th Wednesday night my heart rate went back up to about 140-150. Nov. 11th my heart rate was still up during the day, so I went to get an EKG and they put me in the emergency room on Nov. 11th until it went back down. On Nov. 10th I went to see my cardiologist and I went during the day and my heart rate was normal, so the EKG didn't show any abnormalities. but then on the 11th when my heart rate wasn't normal, and I got the EKG it indicated that I had A-Fib. They gave me saline and prescribed 2 medications for me.
PROQUAD (MMR and Varicella) administered and Varicella administered and same office visit.  Patient's parents notified and evaluated on 8/20/18. Mother reports patient really cranky and having poor appetite, fever on and off. Area in right upper thigh red and swollen 1cm in size. Instructed to take Tylenol for discomfort and fever. Cool compress to the leg. Return if not improving.
Approximately 8 hours after vaccination, vaccination site (1-inch diameter) became red, swollen, itchy, and warm to the touch. As of 3/1/2021 4:30 PM, the itch has resolved. No other symptoms present.
Information has been received from an office manager concerning a female who on an unspecified date was vaccinated intramuscularly with a first dose of GARDASIL. The office manager reported that patient fainted after receiving vaccination. At the time time of reporting, the outcome was unknown. It was not specified if the patient sought medical attention or not. Follow-up information was received from a registered nurse who reported that the patient fainted after receiving the first dose of GARDASIL with immediate recovery. This is one of several reports received from the same source. Additional information has been requested
He got his vaccine, 1st booster, he started with a left leg rash, went to a dermatologist on 3/1/22 and they prescribed the triamcinolone cream, CeraVe ointment and also Vaseline. His leg was wrapped up for a week to 10 days. He was told not to shower more than once a week, and when the bandages came off his leg was bad. He used the ointment again. When he went back to the doctor to have it checked, it was not to his doctors satisfaction and she prescribed betamethasone cream. It seemed to work and it subsided. He got his 2nd booster on 5/24/22, the same thing happened and he went to his dermatologist and told him to go ahead with what he had used before, and this is on the right leg, and got it soon enough that she would not have to wrap his leg and felt that it would not take long. He was still using the CeraVe, Vaseline and ointment, and went back to see her again about 2 weeks ago when it wasn't getting any better, seems to be getting worse. He went to see his PCP to get a 2nd opinion, as it was getting worse and started up on his left leg as well. He saw his PCP today he said that he did not really know what it was, did not want to second guess the dermatologist, and that he should go back to her.  If he wanted a real 2nd opinion to go to another dermatologist.
headache, ataxia, weakness, loss of DTR in lower extremites, treated with steroids. clinical improvement over 7 days. discharged home to follow up with pediatrician, pediatric neurology, pediatric infectious disease, and pediatric rehab. patient also found to have coronavirus (NOT COVID 19) acute infection during illness as well.
By mid after noon of the shot, I was dizzy with a severe headache and had to lay down.  By evening I had chills so bad my teeth chattered while I was running a low fever of 38.7 C. I was delirious in and out of sweats and chills with continuing headache and severe body aches throughout all my muscles and joints. I was nauseous and unable to eat much for a couple of days and had no appetite. I drank water and used my portable oxygen container.  My heart rate on my oximeter fluxuated from 59 and Oxygen at 93 to 137 and Oxygen at 95. I had heart palpitations and a racing heart beat for several days. Though I have asthma, I rarely use and inhaler, perhaps once every couple of months; I use it for rescue only and had not used it for a while. I practice diaphragmatic breathing to relax my spasms.  The headache remained for over ten days along with the racing heart and muscle fatigue. I am still wobbly while walking and don't feel strong. The back of my arm where the injection was is still sore on 3/17/2022.  The injection was a little to the left and lower than my deltoid.  Only after I got home did I read on the preprescription sheet that one should get it in the opposite arm.tthat one should get
5 in x 2 in red circle where administered, skin was tender to the touch everywhere, headache, congestion, cold sx's x 6-7 days.
6th nerve palsy  Infantile (Congenital) Esotropia Strabismus  Approximately a week after child?s first vaccine his eye began turning in.  Now the doctors are considering 6th nerve palsy linked to the vaccine.